Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists–Inverse Agonists with Reduced Withdrawal Effects
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-04-01
|
| Series: | ACS Central Science |
| Online Access: | https://doi.org/10.1021/acscentsci.5c00052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|